AIMS/HYPOTHESIS: Type 2 diabetes is a complex disorder with strong heritability. The aim of our study was to investigate whether common polymorphisms in the genes regulating the early insulin signalling pathway (insulin; A-23T, insulin-like growth factor 1 receptor [IGF-1R]; GAG1013GAA, plasma cell membrane glycoprotein 1 [PC-1]; K121Q, insulin receptor substrate [IRS-1]; G972R, insulin receptor substrate 2 [IRS-2]; G1057D and phosphatidylinositol 3-kinase p85 alpha [PI3K]; M326I) affect the weight change and development of Type 2 diabetes in the Finnish Diabetes Prevention Study. METHODS: We screened for the polymorphisms in 490 overweight subjects with impaired glucose tolerance whose DNA was available from the Finnish Diabetes Prevention Study. These subjects were randomly allocated into a control group and an intervention group characterised by intensive, individualised diet and exercise. RESULTS: In carriers of the GAA1013GAA genotype of IGF-1R, the R972 allele of IRS-1 and the D1057D genotype of IRS-2, lifestyle intervention did not lead to significant differences in weight loss between the intervention and control groups, implying a role of these risk genotypes in the regulation of body weight. We observed a statistically significant difference in the conversion rate from IGT to diabetes between the genotypes of the IGF-1R gene (GAG1013GAG: 18.6%, GAG1013GAA: 10.4%, GAA1013GAA: 19.5%, p=0.033). Common polymorphisms in the insulin, PC-1 and PI3K genes did not regulate weight change or conversion to diabetes. CONCLUSIONS/ INTERPRETATION: The common polymorphisms of the IGF-1R, IRS-1 and IRS-2 genes may modify the weight change response to a lifestyle intervention but not the conversion from IGT to Type 2 diabetes, whereas IGF-1R may also regulate the risk of developing Type 2 diabetes.
RCT Entities:
AIMS/HYPOTHESIS: Type 2 diabetes is a complex disorder with strong heritability. The aim of our study was to investigate whether common polymorphisms in the genes regulating the early insulin signalling pathway (insulin; A-23T, insulin-like growth factor 1 receptor [IGF-1R]; GAG1013GAA, plasma cell membrane glycoprotein 1 [PC-1]; K121Q, insulin receptor substrate [IRS-1]; G972R, insulin receptor substrate 2 [IRS-2]; G1057D and phosphatidylinositol 3-kinase p85 alpha [PI3K]; M326I) affect the weight change and development of Type 2 diabetes in the Finnish Diabetes Prevention Study. METHODS: We screened for the polymorphisms in 490 overweight subjects with impaired glucose tolerance whose DNA was available from the Finnish Diabetes Prevention Study. These subjects were randomly allocated into a control group and an intervention group characterised by intensive, individualised diet and exercise. RESULTS: In carriers of the GAA1013GAA genotype of IGF-1R, the R972 allele of IRS-1 and the D1057D genotype of IRS-2, lifestyle intervention did not lead to significant differences in weight loss between the intervention and control groups, implying a role of these risk genotypes in the regulation of body weight. We observed a statistically significant difference in the conversion rate from IGT to diabetes between the genotypes of the IGF-1R gene (GAG1013GAG: 18.6%, GAG1013GAA: 10.4%, GAA1013GAA: 19.5%, p=0.033). Common polymorphisms in the insulin, PC-1 and PI3K genes did not regulate weight change or conversion to diabetes. CONCLUSIONS/ INTERPRETATION: The common polymorphisms of the IGF-1R, IRS-1 and IRS-2 genes may modify the weight change response to a lifestyle intervention but not the conversion from IGT to Type 2 diabetes, whereas IGF-1R may also regulate the risk of developing Type 2 diabetes.
Authors: A Fritsche; A Madaus; W Renn; O Tschritter; A Teigeler; M Weisser; E Maerker; F Machicao; H Häring; M Stumvoll Journal: J Clin Endocrinol Metab Date: 2001-10 Impact factor: 5.958
Authors: S K Rasmussen; C Lautier; L Hansen; S M Echwald; T Hansen; C T Ekstrøm; S A Urhammer; K Borch-Johnsen; F Grigorescu; R J Smith; O Pedersen Journal: J Clin Endocrinol Metab Date: 2000-04 Impact factor: 5.958
Authors: X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard Journal: Diabetes Care Date: 1997-04 Impact factor: 19.112
Authors: K Almind; S K Frederiksen; D Bernal; T Hansen; L Ambye; S Urhammer; C T Ekstrøm; L Berglund; R Reneland; H Lithell; M F White; E Van Obberghen; O Pedersen Journal: Diabetologia Date: 1999-10 Impact factor: 10.122
Authors: Norbert Stefan; Peter Kovacs; Michael Stumvoll; Robert L Hanson; Angela Lehn-Stefan; Paska A Permana; Leslie J Baier; P Antonio Tataranni; Kristi Silver; Clifton Bogardus Journal: Diabetes Date: 2003-06 Impact factor: 9.461
Authors: N Grarup; S A Urhammer; J Ek; A Albrechtsen; C Glümer; K Borch-Johnsen; T Jørgensen; T Hansen; O Pedersen Journal: Diabetologia Date: 2006-07-25 Impact factor: 10.122
Authors: Philipp Eller; Wilfried Schgoer; Thomas Mueller; Ivan Tancevski; Egon Demetz; Kristina Duwensee; Andreas Ritsch; Meinhard Haltmayer; Josef R Patsch Journal: Heart Vessels Date: 2008-04-04 Impact factor: 2.037
Authors: N Siitonen; J Lindström; J Eriksson; T T Valle; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; J Tuomilehto; M Laakso; M Uusitupa Journal: Diabetologia Date: 2004-07-28 Impact factor: 10.122
Authors: D Meyre; N Bouatia-Naji; V Vatin; J Veslot; C Samson; J Tichet; M Marre; B Balkau; P Froguel Journal: Diabetologia Date: 2007-08-18 Impact factor: 10.122